Should High-Dose Interleukin-2 Still Be the Preferred Treatment for Patients with Metastatic Melanoma?-Reference-Cited by-同舟云学术

Should High-Dose Interleukin-2 Still Be the Preferred Treatment for Patients with Metastatic Melanoma?

Published:2012-08 Issue:6 Volume:27 Page:337-343
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Dillman Robert O.¹,Barth Neil M.¹,VanderMolen Louis A.¹,Mahdavi Khosrow¹,McClure Stephanie E.¹

Affiliation:

1. Medical Oncology Department, Hoag Institute for Research and Education and Hoag Family Cancer Institute, Newport Beach, California.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1220

Reference37 articles.

1. Cancer statistics, 2012

2. Cancer Immunotherapy

3. Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience

4. Hybrid High-dose Bolus/Continuous Infusion Interleukin-2 in Patients with Metastatic Melanoma: A Phase II Trial of the Cancer Biotherapy Research Group (formerly the National Biotherapy Study Group)

5. Tumor-Infiltrating Lymphocytes and Interleukin-2: Dose and Schedules of Administration in the Treatment of Metastatic Cancer

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers;Cancer Drug Resistance;2024-05-13

2. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2020-08

3. Malignant melanoma metastasis in the gallbladder. A case report of an unusual metastatic site;International Journal of Surgery Case Reports;2020

4. Identifying the most effective hydatid cyst fluid fraction for anticancer vaccination of 4T1 breast tumor-bearing mice;International Journal of Preventive Medicine;2019

5. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles;Journal of Immunotherapy;2019-01